|
Molecular determinants of prostate specific antigen (PSA) kinetics and clinical response to apalutamide (APA) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) in SPARTAN. |
|
|
Honoraria - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; Sanofi |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Sanofi |
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst) |
|
|
Honoraria - Astellas Medivation; Bayer; Bayer; Bayer; Janssen Oncology; Janssen Oncology; Janssen Oncology; Janssen Oncology; Sanofi; Valeant/Dendreon |
Consulting or Advisory Role - Exelixis |
Speakers' Bureau - i3 CME |
Research Funding - Janssen Oncology (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Sanofi (Inst) |
Patents, Royalties, Other Intellectual Property - Oncoresponse: Exceptional responders |
Travel, Accommodations, Expenses - Bayer; Clovis Oncology; Merck Sharp & Dohme; Merck Sharp & Dohme; Sanofi |
|
|
Consulting or Advisory Role - Bayer; Janssen; Lightpoint medical |
Research Funding - Janssen |
Patents, Royalties, Other Intellectual Property - Uromed |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Janssen |
|
|
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD Oncology; MSD Oncology; Novartis; Pfizer; Roche; Roche; Sanofi |
Research Funding - Ipsen; Sanofi |
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Merck; MSD Oncology; Novartis; Pfizer; Roche |
|
|
Employment - Xing Technologies |
Leadership - Xing Technologies |
Stock and Other Ownership Interests - Xing Technologies |
Honoraria - Ipsen; Janssen Oncology; Medivation/Astellas; Merck; Novartis; Pfizer; Roche/Genentech |
Consulting or Advisory Role - Janssen Oncology; Pfizer |
Speakers' Bureau - AstraZeneca; Ipsen; Janssen Oncology; Medivation/Astellas; Merck; Novartis; Pfizer; Roche/Genentech |
Research Funding - Merck KGaA |
Patents, Royalties, Other Intellectual Property - 4 patents on nanotechnology |
Travel, Accommodations, Expenses - Ipsen; Janssen Oncology; Medivation/Astellas; Merck; Novartis; Pfizer; Roche/Genentech; Xing Technologies |
|
|
Employment - Johnson & Johnson |
Stock and Other Ownership Interests - Allergan (I) |
|
|
Employment - Janssen Research & Development; Janssen Research & Development |
Stock and Other Ownership Interests - Johnson & Johnson |
Patents, Royalties, Other Intellectual Property - I have several patents pending where I am listed as the inventor that have been developed in the course of my work at Janssen Research and Development. (Inst); I have several patents pending where I am listed as the inventor that have been developed in the course of my work at Janssen Research and Development. (Inst) |
Travel, Accommodations, Expenses - Janssen Research & Development |
|
|
Employment - Janssen Research & Development |
Stock and Other Ownership Interests - Johnson & Johnson |
|
|
Employment - Janssen Research & Development |
Leadership - Janssen Research & Development |
Stock and Other Ownership Interests - Janssen Research & Development |
Research Funding - Janssen Oncology |
Patents, Royalties, Other Intellectual Property - 4 patents (Inst) |
Travel, Accommodations, Expenses - Janssen Research & Development |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Decipher Biosciences; GenomeDx |
Leadership - Decipher Biosciences; GenomeDx |
Stock and Other Ownership Interests - Decipher Biosciences; GenomeDx |
Patents, Royalties, Other Intellectual Property - CANCER DIAGNOSTICS USING BIOMARKERS 20140066323 |
Travel, Accommodations, Expenses - GenomeDx |
|
|
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics |
|
Consulting or Advisory Role - Beigene; Fortis; Janssen Oncology; Teon Therapeutics; Tolero Pharmaceuticals |
Research Funding - Janssen (Inst); Merck (Inst) |
Travel, Accommodations, Expenses - Janssen |
|
|
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Janssen Oncology; Lilly; Novartis; Pfizer |
Research Funding - Bayer (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Lilly (Inst) |
Travel, Accommodations, Expenses - Amgen; Bayer; Janssen; Lilly |
|
|
Leadership - PFS Genomics |
Stock and Other Ownership Interests - Nutcracker Therapeutics, Inc.; PFS Genomics; SerImmune |
|
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Celgene; EMD Serono; Genzyme; Janssen Biotech; Medivation/Astellas |
Research Funding - Zenith Epigenetics |
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst) |